advertisement
Editors Selection IGR 9-2
List of Editor's Selection comments by
Terete Borras
Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
Comments (16-3, June 2015) on:
59479 Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma
Abu-Hassan DW; Li X; Ryan EI et al.
Stem Cells 2015; 33: 751-761
Basic Science: Trabecular meshwork cell loss and regeneration (16-1, December 2014) on:
56161 Outflow tract ablation using a conditionally cytotoxic feline immunodeficiency viral vector
Zhang Z; Dhaliwal AS; Tseng H et al.
Investigative Ophthalmology and Visual Science 2014; 55: 935-940
Basic Research - Outflow: Aqueous outflow resistance (13-3, December 2011) on:
46439 Segmental versican expression in the trabecular meshwork and involvement in outflow facility
Keller KE; Bradley JM; Vranka JA et al.
Investigative Ophthalmology and Visual Science 2011; 52: 5049-5057
Basic Research: Best2 and reduced IOP (12-3, December 2010) on:
25849 Bestrophin 2 is expressed in human non-pigmented ciliary epithelium but not retinal pigment epithelium
Zhang Y; Patil RV; Marmorstein AD
Molecular Vision 2010; 16: 200-206
Comments (12-2, September 2010) on:
26161 Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes
Shepard AR; Millar JC; Pang IH et al.
Investigative Ophthalmology and Visual Science 2010; 51: 2067-2076
Basic Research: Reversing MYOC mutant phenotypes; a new potential treatment (11-3, December 2009) on:
24011 Correction of the disease phenotype of myocilin-causing glaucoma by a natural osmolyte
Jia LY; Gong B; Pang CP et al.
Investigative Ophthalmology and Visual Science 2009; 50: 3743-3749
Basic Research: SMAD7 effect on HTM cells (11-2, September 2009) on:
23718 Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling
Fuchshofer R; Stephan DA; Russell P et al.
Experimental Eye Research 2009; 88: 1020-1032
Medical treatment: Drug delivery to inner wall of Schlemm's Canal (9-2, September 2007) on:
17970 Targeted gene transfer to Schlemm's canal by retroperfusion
Stamer DW; Chan DW; Ross Ethier C
Experimental Eye Research 2007; 84: 843-849
